Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology
Technology provides access to new generation of sensitive biosensors to enhance drug discovery
Domain Therapeutics, a France- and Quebec-based biopharmaceutical compa...


